Clinical Trial Update: Study to Assess Change in Disease Activity and Adverse Events of Ab Externo Approach for Glaucoma Gel Stent (XEN45) Implantation In Participants Aged 45 Years or Older With Open-Angle Glaucoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the Ab Externo approach with the XEN-45 Gel Stent for open-angle glaucoma has completed, with updates on disease activity an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open-angle Glaucoma

Drugs mentioned

• XEN Gel Stent

Snippet

Sponsor: AbbVie | Conditions: Open-Angle Glaucoma | Phase 3 | Status: COMPLETED